Acquisition history Triangle BioSystems International was acquired by Harvard Bioscience, indicating a potential channel shift or strategic alignment opportunities for selling complementary neurotechnology, maintenance, and service offerings to a larger corporate customer base.

Small team footprint With a lean team of 2-10 employees, the company may benefit from scalable, high-impact solutions such as turnkey hardware/software bundles, reseller programs, or managed services to reduce internal R&D workload.

Academic proximity Located in a research-dense corridor (Raleigh-Durham-Chapel Hill) near Duke, UNC, and NC State, there are strong opportunities for research collaborations, pilot programs, and grants-driven purchasing from universities and associated labs.

Neurolab integration Their wireless and tethered neural recording and stimulation hardware that supports rodents and primates aligns with potential upsell opportunities around data analysis software, cloud storage, and cross-platform data interoperability with existing lab ecosystems.

Revenue optimization Current revenue is under $1M; targeting equipment refresh cycles, service contracts, and training packages could create steady recurring revenue while expanding the customer lifetime value within the neurophysiology lab market.